ANTIVIRAL ACTIVITY AND SAFETY OF ITMN-191 IN COMBINATION WITH PEGINTERFERON ALFA-2A AND RIBAVIRIN IN PATIENTS WITH CHRONIC HEPATITIS C VIRUS (HCV)

被引：12
|
作者：
Forestier, N. [1 ]
Larrey, D. [2 ]
Marcellin, P. [3 ]
Benhamou, Y. [4 ]
Guyader, D. [5 ]
Bradford, W. [6 ]
Porter, S. [6 ]
Patat, A. [7 ]
Rouzier, R. [8 ]
Zeuzem, S. [1 ]
机构：
[1] Univ Frankfurt, Frankfurt, Germany
[2] CHU Montpellier, Montpellier, France
[3] Hop Beaujon, Clichy, France
[4] AP HP, Paris, France
[5] CHU Hop Ponchaillou, Rennes, France
[6] Intermune Inc, Brisbane, CA USA
[7] Biotrial, Rennes, France
[8] Ctr CAP, Montpellier, France
来源：
JOURNAL OF HEPATOLOGY | 2009年 / 50卷
关键词：
D O I：
10.1016/S0168-8278(09)60087-8
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
85
引用
收藏
页码：S35 / S35
页数：1
相关论文
共 50 条
  • [41] Impact of ribavirin dose reductions in hepatitis C virus genotype 1 patients completing peginterferon alfa-2a/ribavirin treatment
    Reddy, K. Rajender
    Shiffman, Mitchell L.
    Morgan, Timothy R.
    Zeuzem, Stefan
    Hadziyannis, Stephanos
    Hamzeh, Fayez M.
    Wright, Teresa L.
    Fried, Michael
    [J]. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2007, 5 (01) : 124 - 129
  • [42] Pharmacoeconomic analysis of the treatment of chronic hepatitis C with peginterferon alfa-2a or peginterferon alfa-2b plus ribavirin in Spain
    Turnes, Juan
    Romero-Gomez, Manuel
    Planas, Ramon
    Sola, Ricard
    Garcia-Samaniego, Javier
    Diago, Moises
    Crespo, Javier
    Calleja, Jose Luis
    Rubio-Terres, Carlos
    Ventayol, Pere
    [J]. GASTROENTEROLOGIA Y HEPATOLOGIA, 2013, 36 (09): : 555 - 564
  • [43] R1626 plus peginterferon alfa-2a provides potent suppression of hepatitis C virus RNA and significant antiviral synergy in combination with ribavirin
    Pockros, Paul J.
    Nelson, David
    Godofsky, Eliot
    Rodriguez-Torres, Maribel
    Everson, Gregory T.
    Fried, Michael W.
    Ghalib, Reem
    Harrison, Stephen
    Nyberg, Lisa
    Shiffman, Mitchell L.
    Najera, Isabel
    Chan, Anna
    Hill, George
    [J]. HEPATOLOGY, 2008, 48 (02) : 385 - 397
  • [44] GENERALIZED ECZEMA SECONDARY TO COMBINED TREATMENT WITH PEGINTERFERON ALFA-2A AND RIBAVIRIN IN A PATIENT WITH CHRONIC HEPATITIS FROM THE HEPATITIS C VIRUS
    de Casas, Andres Ruiz
    Garcia-Bravo, Begona
    Camacho, Francisco
    [J]. ACTAS DERMO-SIFILIOGRAFICAS, 2005, 96 (02): : 122 - 123
  • [45] Age-related differences in response to peginterferon alfa-2a/ribavirin in patients with chronic hepatitis C infection
    Roeder, Claudia
    Jordan, Sabine
    zur Wiesch, Julian Schulze
    Pfeiffer-Vornkahl, Heike
    Hueppe, Dietrich
    Mauss, Stefan
    Zehnter, Elmar
    Stoll, Sabine
    Alshuth, Ulrich
    Lohse, Ansgar W.
    Lueth, Stefan
    [J]. WORLD JOURNAL OF GASTROENTEROLOGY, 2014, 20 (31) : 10984 - 10993
  • [46] Age-related differences in response to peginterferon alfa-2a/ribavirin in patients with chronic hepatitis C infection
    Claudia Roeder
    Sabine Jordan
    Julian Schulze zur Wiesch
    Heike Pfeiffer-Vornkahl
    Dietrich Hueppe
    Stefan Mauss
    Elmar Zehnter
    Sabine Stoll
    Ulrich Alshuth
    Ansgar W Lohse
    Stefan Lueth
    [J]. World Journal of Gastroenterology, 2014, (31) : 10984 - 10993
  • [47] Peginterferon Alfa-2b or Alfa-2a with Ribavirin for Treatment of Hepatitis C Infection
    McHutchison, John G.
    Lawitz, Eric J.
    Shiffman, Mitchell L.
    Muir, Andrew J.
    Galler, Greg W.
    McCone, Jonathan
    Nyberg, Lisa M.
    Lee, William M.
    Ghalib, Reem H.
    Schiff, Eugene R.
    Galati, Joseph S.
    Bacon, Bruce R.
    Davis, Mitchell N.
    Mukhopadhyay, Pabak
    Koury, Kenneth
    Noviello, Stephanie
    Pedicone, Lisa D.
    Brass, Clifford A.
    Albrecht, Janice K.
    Sulkowski, Mark S.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2009, 361 (06): : 580 - 593
  • [48] A comparison of sustained viral response in patients with chronic hepatitis C virus (HCV) treated with peginterferon alfa-2a (Peg2a) versus peginterferon alfa-2b (Peg2b) and ribavirin
    Poordad, F
    Tran, TT
    Ayoub, W
    Patel, Y
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2005, 100 (09): : S130 - S130
  • [49] INCIDENCE OF VIROLOGIC ESCAPE OBSERVED DURING ITMN-191 (R7227) MONOTHERAPY IS GENOTYPE DEPENDENT, ASSOCIATED WITH A SPECIFIC NS3 SUBSTITUTION, AND SUPPRESSED UPON COMBINATION WITH PEGINTERFERON ALFA-2A/RIBAVIRIN
    Sarrazin, C.
    Hong, J.
    Lim, S.
    Qin, X.
    Susser, S.
    Bradford, B.
    Porter, S.
    Zeuzem, S.
    Seiwert, S.
    [J]. JOURNAL OF HEPATOLOGY, 2009, 50 : S350 - S350
  • [50] Association of Host Pharmacodynamic Effects and Virologic Response to Peginterferon Alfa-2a/Ribavirin in Patients With Chronic Hepatitis C
    Chung, Raymond T.
    Di Bisceglie, Adrian M.
    Poordad, Fred
    Hassanein, Tarek
    Zhou, Xiaolei
    Lentz, Ellen
    Prabhakar, Avi
    Hamzeh, Fayez M.
    [J]. GASTROENTEROLOGY, 2010, 138 (05) : S841 - S841
12345